BlinkLab

Blinklab Commences Partnership with Turning Pointe Autism Foundation for Clinical Study in Children with Autism in the US

BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”), an innovative digital healthcare company developing smartphone-based AI powered diagnostic tests for autism, today announced that it initiated a clinical study in partnership with US based Turning Pointe Autism Foundation. The study will enroll up to one hundred children previously diagnosed with autism and one hundred children without an autism diagnosis. The data obtained during the course of this collaboration will be used to finalize the data collection and processing algorithms as well as AI/ML models ahead of the FDA registrational study expected to start in the second half of 2024.


Highlights

  • Strategic partnership initiated with US Based Turning Pointe Autism Foundation, to conduct a clinical study using AI-powered diagnostic tools developed for autism.
  • The study will involve up to two hundred children aiming to finalize the artificial intelligence/machine learning (“AI/ML”) algorithms and models for a larger FDA registration study planned for the second half of 2024.
  • This study aligns with regulatory preparations, setting the stage for an FDA registrational study.
  • The collaboration agreement ensures that any intellectual property developed as a direct result of the partnership will be owned by BlinkLab.
Founded in 2007, Turning Pointe Autism Foundation in Naperville, Illinois, was created to meet the specific and unique needs of students learning with autism. It offers individuals with autism between 5 to 22 years of age best practice programs to support their growth, development, and employment. To date, Turning Pointe’s commitment has had an impact on enhancing independence, communication, and social interactions among hundreds of children, teens, and adults. This collaboration between Turning Pointe and BlinkLab supports its vision to remain at the intersection of hope and innovation.

BlinkLab is proud to bring its innovative neurobehavioral tests to Turning Pointe’s programs. These tests, which can be easily administered via smartphone, are a game-changer in making diagnostic tools more accessible. BlinkLab’s initial focus will be on a pilot program involving students from Turning Pointe aimed at refining and improving the data collection and processing algorithms as well as our AI/Machine Learning models.

Henk-Jan Boele, CEO of BlinkLab commented:

“Our partnership with Turning Pointe is more than just collaboration. It is a major step toward fulfilling our mission to make well-established neurobehavioral testing clinically accessible and efficient. Turning Pointe’s dedication to quality education and support aligns perfectly with our goal of leveraging cutting-edge technology to better understand and assist individuals with autism. We are very excited about the possibilities that this collaboration offers for the advancement of autism diagnosis and care.”

Brian Leedman, Chairman of BlinkLab commented:

“I am excited to see that our first substantive news following our listing a few weeks ago is a collaboration with this prestigious group in the field of autism research in children. I anticipate many more important announcements such as these as we get closer to the commencement of our FDA registration study later this year”.

Study design and experimental setup

Neurobehavioral testing will be performed using the smartphone-based platform developed by BlinkLab. The tests will include general measurement of spontaneous and stimulus-evoked postural, head, facial, and vocal responses along with specific neurometric tests, including the acoustic startle response, prepulse inhibition, long-term habituation, and short-term habituation. Up to two hundred children will participate in the study. During the 15-minute smartphone evaluations, the children will watch an audio-normalized movie while the trials containing the auditory stimuli will be delivered via headphones. For each trial, computer vision algorithms will be used to track and record the position of the participant’s facial landmarks over time. The study will be performed in accordance with relevant guidelines and regulations and study protocol was reviewed and approved by the institutional review board of Princeton University (#13943) and Turning Pointe Autism Foundation.


Click here for the full ASX Release

This article includes content from Blinklab Limited, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.


BB1:AU
The Conversation (0)
NVIDIA logo.

NVIDIA Delivers Record Quarter as AI Demand Booms, but China Uncertainty Persists

NVIDIA (NASDAQ:NVDA) delivered another blockbuster quarter, reporting record revenue of US$46.7 billion for its second fiscal period as demand for artificial intelligence (AI) infrastructure continues to surge.

The chipmaking giant said sales rose 56 percent from a year earlier and 6 percent from the prior quarter, marking the ninth straight period of year-on-year revenue growth above 50 percent.

Meanwhile, NVIDIA's net income jumped 59 percent to US$26.42 billion from US$16.6 billion. Its adjusted earnings per share were US$1.05, beating analyst forecasts of US$1.01.

Keep reading...Show less
Digital globe with glowing blue patterns and network connections.

ResetData Creates New Public Sovereign AI Supercomputer in Australia

Australian cloud provider ResetData, part of Centuria Capital Group (ASX:CNI), has unveiled AI-F1, a public sovereign artificial intelligence (AI) supercomputer located in Australia.

AI-F1 offers onshore, high-performance AI computing resources for the government, academic and business sectors.

The multi-megawatt supercomputer allows customers to leverage NVIDIA's (NASDAQ:NVDA) NIM microservices, which are designed to work on machine learning and large language models.

Keep reading...Show less
Futuristic 3D microchip with glowing circuits on a blue background.

NVIDIA's Latest AI Chip Comes at Crucial Moment Before Earnings Report

Reports are circulating that NVIDIA (NASDAQ:NVDA) is quietly preparing a new artificial intelligence (AI) chip for China that would surpass the performance of its current H20 model.

The move comes as the US weighs how much access Chinese companies should have to American technology.

Two people briefed on the matter told Reuters that the chip, tentatively called the B30A, is based on NVIDIA's latest Blackwell architecture and is expected to deliver roughly half the computing power of the company’s flagship dual-die B300 accelerator card. Like the H20, the new chip is rumored to include high-bandwidth memory and NVLink interconnect technology, but would offer more power for Chinese clients.

Keep reading...Show less
Two businesspeople shaking hands over financial graphs and "Tech 5" text.

Tech 5: US Government Strikes Big Tech Deal, Perplexity Plots Expansion

Tech stocks led Wall Street to a second consecutive week of gains as a series of data releases reignited optimism about a September interest rate cut from the US Federal Reserve.

A strong consumer price index report was the catalyst, renewing anticipation that the Fed will lower rates when it meets next month. While Thursday's (August 14) less optimistic producer price index report caused a momentary pause, the tech sector's resilience — or defiance — mitigated losses and kept momentum alive.

Here's a look at the key moments that shaped the tech sector this week.

Keep reading...Show less

Latest Press Releases

Related News

×